VATE
Get informed when a big investor buys or sells
+ FollowOvervalued by 230.2% based on the discounted cash flow analysis.
| Market cap | $107.23 Million |
|---|---|
| Enterprise Value | $211.73 Million |
| Dividend Yield | $0.78 (9.92%) |
| Earnings per Share | $-4.84 |
| Beta | 2.37 |
| Outstanding Shares | 13,374,803 |
| P/E Ratio | -4.27 |
|---|---|
| PEG | 2.77 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 3.82 |
| Enterprise Value to Revenue | 0.14 |
| Enterprise Value to EBIT | -14.21 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 3.11 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 17.99%▼ 0.65% |
|---|---|
| Total Invested | $13.63M▲ 21.30% |
| Investors Holding | 31▲ 3.00% |
No data
HC2 Holdings, Inc.has a class-leading portfolio of assets primarily in Infrastructure, Life Sciences, Spectrum and Insurance. HC2 is headquartered in New York, New York and through its subsidiaries employs more than 2,800 people.